Literature DB >> 7479937

Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features.

K G Warren1, I Catz, L Steinman.   

Abstract

T cells, B cells, and antibody are found in the white matter of the central nervous system in multiple sclerosis. The epitope center for the antibody response to human myelin basic protein (MBP) fits precisely the minimal epitope Pro85-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro96 for that reported for HLA DR2b (DRB1*1501)-restricted T cells that recognize MBP [Wucherpfenning, K.W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. & Hafler, D. (1994) J. Exp. Med. 179, 279-290], and overlaps with the reported DR2a-restricted epitope for T cells reactive to MBP [Martin, R., Howell, M. D., Jaraquemada, D., Furlage, M., Richert, J., Brostoff, S., Long, E. O., McFarlin, D. E. & McFarland, H. F. (1991) J. Exp. Med. 173, 19-24]. We describe a molecular model of this epitope.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479937      PMCID: PMC40571          DOI: 10.1073/pnas.92.24.11061

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Possible hydrophobic region in myelin basic protein consisting of an orthogonally packed beta-sheet.

Authors:  R E Martenson
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

2.  Amino acid sequence of the encephalitogenic basic protein from human myelin.

Authors:  P R Carnegie
Journal:  Biochem J       Date:  1971-06       Impact factor: 3.857

3.  Antigenic determinants of bovine myelin encephalitogenic protein recognized by rabbit antibody to myelin encephalitogenic protein.

Authors:  J N Whitaker; C H Jen Chou; F C Chou; R F Kibler
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

Review 4.  Major T-cell responses in multiple sclerosis.

Authors:  L Steinman; A Waisman; D Altmann
Journal:  Mol Med Today       Date:  1995-05

5.  Predicted folding of beta-structure in myelin basic protein.

Authors:  G L Stoner
Journal:  J Neurochem       Date:  1984-08       Impact factor: 5.372

6.  Lipid/myelin basic protein multilayers. A model for the cytoplasmic space in central nervous system myelin.

Authors:  J Sedzik; A E Blaurock; M Höchli
Journal:  J Mol Biol       Date:  1984-04-05       Impact factor: 5.469

7.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Authors:  K Banki; E Colombo; F Sia; D Halladay; D H Mattson; A H Tatum; P T Massa; P E Phillips; A Perl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

8.  Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.

Authors:  N Karin; D J Mitchell; S Brocke; N Ling; L Steinman
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  Molecular internalization of a region of myelin basic protein.

Authors:  J N Whitaker; C H Chou; F C Chou; R F Kibler
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

View more
  23 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Antigen specific immunotherapy of multiple sclerosis.

Authors:  L Steinman; P Conlon
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

3.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 4.  Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet.

Authors:  Lawrence Steinman
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 5.  A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry.

Authors:  L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

6.  Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope.

Authors:  Natalie K Cygan; Johanna C Scheinost; Terry D Butters; Paul Wentworth
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

7.  Autoimmunity due to molecular mimicry as a cause of neurological disease.

Authors:  Michael C Levin; Sang Min Lee; Franck Kalume; Yvette Morcos; F Curtis Dohan; Karen A Hasty; Joseph C Callaway; Joseph Zunt; Dominic Desiderio; John M Stuart
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

8.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

9.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

10.  Molecular dynamics exposes alpha-helices in myelin basic protein.

Authors:  Ian R Bates; George Harauz
Journal:  J Mol Model       Date:  2003-07-24       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.